March 18-21, 2025
San Diego Convention CenterSan Diego, CA, USA Nick TimminsCSO at Syntax BioSpeaker
Profile
With over 20-years’ experience in the development of CGT’s and related technologies, Nick has covered a broad variety of cell types, applications, and tools in various regions around the world. Currently CSO at Syntax Bio, he has previously held the potions of
CDO at Artisan Bio, VP Process Development at BlueRock Therapeutics, VP Technology at CCRM and Director of the Center for Advanced Therapeutic Cell Technologies, and Strategic Consultant for several start-ups.
Agenda Sessions
Direct Permutational Control of Transcription Factor Networks for Precision Cell Differentiation – Reducing Manufacturing Complexity and Duration
, 11:30amView Session